5% Bisphosphocin Topical Gel
LLA-Nu-3-CLIN002
Phase 2 small_molecule terminated
Quick answer
5% Bisphosphocin Topical Gel for Chronic Diabetic Foot Ulcers is a Phase 2 program (small_molecule) at Lakewood-Amedex Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Lakewood-Amedex Biotherapeutics
- Indication
- Chronic Diabetic Foot Ulcers
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated